4//SEC Filing
Silberstein Charles 4
Accession 0001209191-21-039723
CIK 0001697532other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 9:01 PM ET
Size
5.5 KB
Accession
0001209191-21-039723
Insider Transaction Report
Form 4
Silberstein Charles
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-06-08$21.42/sh−5,047$108,107→ 87,803 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]Weighted average price. These shares were sold in multiple transactions at prices ranging from $20.8500 to $21.2400 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001813117
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 9:01 PM ET
- Size
- 5.5 KB